id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-256634-gg8hptfg	Rhodes, N. J.	Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19	2020-06-06		.txt	text/plain	4107	260	50	Conclusions: While we observed high rates of supportive care for patients with COVID-19, we also found that ADRs were common among patients receiving drug therapy including in clinical trials. The objective of this point-prevalence study was to characterize the drug therapies used in the management of COVID-19, including supportive care and combination therapies, in an attempt to identify safety signals among acutely ill hospitalized patients. Data elements collected included facility demographics, total number of hospital and ICU beds prior to the pandemic, U.S. Census region location, patient populations served, facility type (e.g., academic, community, inpatient rehabilitation), and active clinical trial site status. In addition to whether patients were receiving supportive care or drug therapies targeted at SARS-CoV-2, we collected basic patient demographic information and vital status (e.g., age, sex, comorbidities, oxygen requirement, and ICU status). Patients were significantly more likely to receive COVID-19 directed drug therapy if they were enrolled in a clinical trial (26.9% vs 3.2%; P <0.001).	./cache/cord-256634-gg8hptfg.txt	./txt/cord-256634-gg8hptfg.txt